Works matching IS 10507256 AND DT 2024 AND VI 34 AND IP 1


Results: 18
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.

    Published in:
    Thyroid, 2024, v. 34, n. 1, p. 26, doi. 10.1089/thy.2023.0363
    By:
    • Subbiah, Vivek;
    • Hu, Mimi I.;
    • Mansfield, Aaron S.;
    • Taylor, Matthew H.;
    • Schuler, Martin;
    • Zhu, Viola W.;
    • Hadoux, Julien;
    • Curigliano, Giuseppe;
    • Wirth, Lori;
    • Gainor, Justin F.;
    • Alonso, Guzman;
    • Adkins, Douglas;
    • Godbert, Yann;
    • Ahn, Myung-Ju;
    • Cassier, Philippe A.;
    • Cho, Byoung Chul;
    • Lin, Chia-Chi;
    • Zalutskaya, Alena;
    • Barata, Teresa;
    • Trask, Peter
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    17